Acadia Pharmaceuticals (ACAD) FCF Margin Growth (1y) (2011 - 2026)
Acadia Pharmaceuticals (ACAD) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.00 |
| Dec 31, 2025 | -3,395.00 |
| Sep 30, 2025 | 129.00 |
| Jun 30, 2025 | 1,372.00 |
| Mar 31, 2025 | -581.00 |
| Dec 31, 2024 | -2,158.00 |
| Sep 30, 2024 | 5,308.00 |
| Jun 30, 2024 | 537.00 |
| Mar 31, 2024 | 2,927.00 |
| Dec 31, 2023 | 5,444.00 |
| Sep 30, 2023 | -2,729.00 |
| Jun 30, 2023 | 1,472.00 |
| Mar 31, 2023 | 5,097.00 |
| Dec 31, 2022 | 21.00 |
| Sep 30, 2022 | 1,241.00 |
| Jun 30, 2022 | 1,227.00 |
| Mar 31, 2022 | -864.00 |
| Dec 31, 2021 | 669.00 |
| Sep 30, 2021 | 737.00 |
| Jun 30, 2021 | 1,414.00 |